ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/006/SRR8763926/SRR8763926.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/009/SRR8763909/SRR8763909.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/003/SRR8763913/SRR8763913.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/001/SRR8763911/SRR8763911.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/007/SRR8763907/SRR8763907.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/005/SRR8763915/SRR8763915.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/008/SRR8763918/SRR8763918.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/002/SRR8763922/SRR8763922.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/001/SRR8763921/SRR8763921.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/004/SRR8763924/SRR8763924.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/006/SRR8763916/SRR8763916.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/005/SRR8763925/SRR8763925.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/008/SRR8763908/SRR8763908.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/007/SRR8763927/SRR8763927.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/009/SRR8763919/SRR8763919.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/004/SRR8763914/SRR8763914.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/000/SRR8763910/SRR8763910.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/007/SRR8763917/SRR8763917.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/000/SRR8763920/SRR8763920.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/003/SRR8763923/SRR8763923.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR876/002/SRR8763912/SRR8763912.fastq.gzprimaryOK200GenomicsLaboratory for Translational Genetics, Human Genetics, KU Leuvenhttps://www.ebi.ac.uk/ena/browser/view/PRJNA528491This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual SeriesENAfalseRNA-seq and DNA methylation and hydroxymethylation profiles in sensitive and treatment-resistant cancer cell linesRNA-seq and DNA methylation and hydroxymethylation profiles in sensitive and treatment-resistant cancer cell lines2025-09-242020-02-17PRJNA528491GSE128686